Novel approaches to food allergy (Q38074866)

28 August 2017

1 reference

title

Novel approaches to food allergy (English)

1 reference

28 August 2017

Yao-Hsu Yang

1

1 reference

28 August 2017

Bor-Luen Chiang

series ordinal

2

1 reference

28 August 2017

publication date

1 June 2014

1 reference

Clinical Reviews in Allergy & Immunology

28 August 2017

published in

1 reference

28 August 2017

volume

46

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

250-257

1 reference

Epidemiology of food allergy

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Future therapies for food allergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Time trends in allergic disorders in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Effect of anti-IgE therapy in patients with peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Effects of omalizumab in patients with food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Clinical immunology review series: an approach to desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Treatment of peanut allergy with rush immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Food allergy and oral allergy or pollen-food syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Oral immunotherapy for food allergy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Egg oral immunotherapy in nonanaphylactic children with egg allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Successful oral tolerance induction in severe peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Clinical efficacy and immune regulation with peanut oral immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

An update on immunotherapy for food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Modified recombinant allergens for safer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Tolerance to extensively heated milk in children with cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Immunologic changes in children with egg allergy ingesting extensively heated egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Dietary baked milk accelerates the resolution of cow's milk allergy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Epitope peptides and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Gene therapy for allergic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

DNA vaccines and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Ara h 1-reactive T cells in individuals with peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

Specific oral tolerance induction in children with very severe cow's milk–induced reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12016-013-8354-2

21 January 2018

Allergen immunotherapy

1 reference

12 December 2020

1 reference

12 December 2020

Omalizumab: a recombinant humanized monoclonal IgE-blocking antibody.

1 reference

12 December 2020

Sublingual Immunotherapy

1 reference

12 December 2020

Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract

1 reference

12 December 2020

Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity

1 reference

12 December 2020

Pioneering immunotherapy for food allergy: clinical outcomes and modulation of the immune response

1 reference

12 December 2020

Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients

1 reference

12 December 2020

1 reference

12 December 2020

Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice.

1 reference

12 December 2020

Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously

1 reference

12 December 2020

Mechanisms of allergen-specific immunotherapy

1 reference

12 December 2020

Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract

1 reference

12 December 2020

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

1 reference

12 December 2020

Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study

1 reference

12 December 2020

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract1

1 reference

12 December 2020

10.1007/S12016-013-8354-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1033859108

0 references

1 reference